We are live on
!
Find out more
NRC
North Run Capital Portfolio holdings
AUM
$43.5M
1-Year Est. Return
38.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.38%
1 Year Est. Return
-38.24%
3 Year Est. Return
+19.43%
5 Year Est. Return
+17.57%
10 Year Est. Return
–
AUM
$984M
AUM Growth
+$195M
(+25%)
Cap. Flow
+$125M
Cap. Flow
% of AUM
12.68%
Top 10 Holdings %
Top 10 Hldgs %
60.41%
Holding
34
New
10
Increased
4
Reduced
11
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIBX
TIBCO SOFTWARE INC
TIBX
|
+$54.5M |
| 2 |
Visteon
VC
|
+$49.1M |
| 3 |
INXN
Interxion Holding N.V.
INXN
|
+$44.6M |
| 4 |
SIR
SELECT INCOME REIT
SIR
|
+$28.3M |
| 5 |
General Motors
GM
|
+$25.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$54.3M |
| 2 |
AET
Aetna Inc
AET
|
+$29M |
| 3 |
Acacia Research
ACTG
|
+$22.2M |
| 4 |
HNT
HEALTH NET INC
HNT
|
+$20.5M |
| 5 |
QVCGA
QVC Group Inc Series A
QVCGA
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.66% |
| 2 | Consumer Discretionary | 22.49% |
| 3 | Financials | 11.44% |
| 4 | Industrials | 8.2% |
| 5 | Real Estate | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Brookdale Senior Living
BKD
$3.49B
| $73.7M | 7.49% |
2,200,000
-262,969
| -11% | -$7.96M |
|
|
2
Teva Pharmaceuticals
TEVA
$40.8B
| $62.1M | 6.31% |
1,175,000
-1,175,000
| -50% | -$54.3M |
|
|
3
General Motors
GM
$80.4B
| $61.8M | 6.28% |
1,795,000
+690,000
| +62% | +$25.3M |
|
4
H&R Block
HRB
$5.58B
| $59.6M | 6.06% |
1,975,000
+433,000
| +28% | +$13M |
|
|
HNT
5
DELISTED
HEALTH NET INC
HNT
| $59.3M | 6.03% |
1,745,000
-625,000
| -26% | -$20.5M |
|
|
ETFC
6
DELISTED
E*Trade Financial Corporation
ETFC
| $58.7M | 5.97% |
2,550,000
+451,106
| +21% | +$9.88M |
|
7
ATI
ATI
$25.6B
| $58.4M | 5.94% |
1,550,000
| – | – |
|
|
HSP
8
DELISTED
HOSPIRA INC
HSP
| $57.5M | 5.85% |
1,330,400
-34,600
| -3% | -$1.48M |
|
|
9
Visteon
VC
$2.79B
| $52.2M | 5.3% |
+590,000
| New | +$49.1M |
|
|
TIBX
10
DELISTED
TIBCO SOFTWARE INC
TIBX
| $51M | 5.18% |
+2,509,850
| New | +$54.5M |
|
11
The Mosaic Company
MOS
$7.03B
| $44.8M | 4.55% |
895,000
| – | – |
|
|
AET
12
DELISTED
Aetna Inc
AET
| $44.2M | 4.5% |
590,000
-410,000
| -41% | -$29M |
|
|
INXN
13
DELISTED
Interxion Holding N.V.
INXN
| $44.1M | 4.48% |
+1,840,200
| New | +$44.6M |
|
14
Boston Scientific
BSX
$69.5B
| $37.2M | 3.79% |
2,755,000
-530,000
| -16% | -$6.96M |
|
|
NRF
15
DELISTED
NorthStar Realty Finance Corp.
NRF
| $35.5M | 3.61% |
1,120,350
+679,767
| +154% | +$20M |
|
|
SIR
16
DELISTED
SELECT INCOME REIT
SIR
| $30.3M | 3.08% |
+2,275,000
| New | +$28.3M |
|
|
NETI
17
DELISTED
Eneti Inc.
NETI
| $22.2M | 2.26% |
+19,727
| New | +$21.5M |
|
|
NWY
18
DELISTED
New York & Co Inc
NWY
| $17.5M | 1.78% |
3,995,973
| – | – |
|
19
Progress Software
PRGS
$1.66B
| $14.2M | 1.44% |
+650,000
| New | +$15.6M |
|
|
QVCGA
20
DELISTED
QVC Group Inc Series A
QVCGA
| $13.5M | 1.38% |
11,426
-11,949
| -51% | -$14M |
|
|
ALIM
21
DELISTED
Alimera Sciences
ALIM
| $12.7M | 1.3% |
107,705
-1,186
| -1% | -$115K |
|
|
XXIA
22
DELISTED
Ixia
XXIA
| $11.9M | 1.21% |
+952,735
| New | +$12.2M |
|
23
Telephone and Data Systems
TDS
$3.82B
| $11.3M | 1.15% |
+432,967
| New | +$11M |
|
|
LOV
24
DELISTED
Spark Networks SE American Depositary Shares
LOV
| $9.71M | 0.99% |
1,855,856
| – | – |
|
|
GTS
25
DELISTED
Triple-S Management Corporation
GTS
| $9.67M | 0.98% |
629,591
-365,156
| -37% | -$6.08M |
|
Similar funds
ACM
HA
JI
CCS
BGP
EOCM
SJIA
LN
North Run Capital's Q1 2014 Portfolio in Review
As of Q1 2014, North Run Capital held 34 positions worth $984M, up 25% from $789M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
North Run Capital deployed $125M of net new capital in Q1 2014, opening 10 new positions and adding to 4 existing holdings. Its largest new stake was TIBCO SOFTWARE INC: 2,509,850 shares worth $51M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 44% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $54.3M trimmed.
- North Run Capital's largest Q1 2014 buy was TIBCO SOFTWARE INC: 2,509,850 shares worth $51M.
- North Run Capital added most to General Motors in Q1 2014, an estimated $25.3M increase.
- North Run Capital's biggest Q1 2014 reduction was Teva Pharmaceuticals, cutting an estimated $54.3M.
- North Run Capital fully exited Acacia Research in Q1 2014, selling an estimated $22.2M.
- North Run Capital's ten largest holdings make up 60% of its $984M portfolio in Q1 2014.
- North Run Capital opened 10 new positions and closed 4 in Q1 2014.
- North Run Capital's portfolio value rose 25% quarter-over-quarter to $984M.
Based on North Run Capital's 13F filing for Q1 2014, filed 15 May 2014.